Nordex SE

Good start might put upper end of the EBITDA guidance within reach

14/05/24 -"Nordex had a good start to the year with sales and EBITDA better than our expectations. Sales growth and the gross margin were supported by better execution, higher pricing and a favourable mix. This ..."

PDF page sample
Pages
55
Language
English
Published on
14/05/24
Download
You may also be interested by these reports :
05/11/26
Rational’s 3Q26 beat expectations. Sales grew 6% to €332.2m, in line, while EBIT of €91.3m came in 11% above consensus. Tariff provision releases ...
04/11/26
Wärtsilä’s CMD confirmed its upgraded medium-term targets while providing greater visibility on Energy deliveries, profitability and future service ...
04/11/26
We upgrade Sulzer from Reduce to Add. Our previous stance reflected weak industrial capex, Chemtech’s weakness and execution risk on large projects. ...
03/11/26
We have cut our target price from c.€20 per share to approximately €12 per share owing to substantial cuts to our DCF and NAV valuation, along with a ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO